Counselors in Cornwall, NY Accepting Medicare

6 Counselors found. Showing 1 - 6

Elle Laub, LMHC, LPC, NCC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 7 Orr Hatch, Cornwall, NY 12518 Phone: 650-235-0048

Mrs. Amanda Lee Dixon, LMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 21 Laurel Ave, Cornwall, NY 12518 Phone: 845-235-2267

Miss Lisa Marie Cardona, LMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 21 Laurel Ave, Cornwall, NY 12518 Phone: 845-458-4557

Joanna Lunin, RN, LMHC-LP Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 10 Elm St, Cornwall, NY 12518 Phone: 845-535-9481

Elena Julia Morales, LMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 21 Laurel Ave, Suite 290, Cornwall, NY 12518 Phone: 845-551-2323    Fax: 845-458-4559

Antoniella Delvecchio, CASAC-T Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 246 Main St, Suite 2, Cornwall, NY 12518 Phone: 845-863-5487

News Archive

Impact of COVID-19 pandemic on children's and adolescents' lifestyle behaviors

A new study describes changes in physical activity, screen time, and sleep duration in Swiss children during the pandemic, and how these correlated with well-being.

Textual communication using smartphones can change rhythm of brain waves

Sending text messages on a smartphone can change the rhythm of brain waves, according to a new study published in Epilepsy & Behavior.

Catalyst Pharmaceutical raises $3.97 million from institutional investors

Catalyst Pharmaceutical Partners, Inc. today announced that it has closed its previously announced registered direct offering of 3.97 million shares of its common stock to institutional investors at a price per share of $1.00, representing gross proceeds of $3.97 million.

Novel drug increases survival in animal models exposed to high-dose radiation

A novel drug that mimics a naturally occurring molecule found in coffee and blueberries has been developed to treat radiation exposure. Charles R. Yates, Pharm.D., Ph.D., and colleagues Duane Miller, Ph.D., and Waleed Gaber, Ph.D., from the University of Tennessee Health Science Center and Baylor College of Medicine, show that application of this drug, starting 24 hours after radiation exposure, increases survival in animal models by three-fold compared to placebo.

ZOLL Medical's second-quarter revenues up 15% to $107.1 million

ZOLL Medical Corporation, a manufacturer of resuscitation devices and software solutions, today announced that revenues for the second quarter of fiscal 2010 increased 15% to $107.1 million, compared to revenues in the second quarter of last year of $92.7 million. Revenue results included a positive foreign exchange impact of approximately $2.2 million, compared to the second quarter of fiscal 2009.

Read more Medical News

› Verified 9 days ago